Skip to content

Clinical trials

Phase 4 Diabetic Retinopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Phase 4 Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20061
20072
20091
20102
20114
20122
20133
20153
20161
20173
20182
20193
20205
20215
20221
20243
20251
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Unknown status10
Recruiting3
Not yet recruiting3
Withdrawn2
Enrolling by invitation2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cairo University3
Novartis Pharmaceuticals3
Moorfields Eye Hospital NHS Foundation Trust2
Ruijin Hospital2
Ahmad Zeeshan Jamil1
Ain Shams University1
Alaa Hassan ElBaz1
Alimera Sciences1
Asociación para Evitar la Ceguera en México1
California Retina Consultants1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy51
Diabetes Mellitus11
Macular Edema7
Macular Degeneration4
Retinal Diseases3
Diabetes Complications2
Diabetes Mellitus, Type 22
Retinal Vein Occlusion2
Vitreous Hemorrhage2
Aneurysm1

Trials

Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.